Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?
Tóm tắt
Anorexia nervosa carries the highest mortality rate of any psychiatric disorder. Even the most critically ill anorexic patients may present with normal 'standard' laboratory values, underscoring the need for a new sensitive biomarker. The complement cascade, a major component of innate immunity, represents a driving force in the pathophysiology of multiple inflammatory disorders. The role of complement in anorexia nervosa remains poorly understood. The present study was designed to evaluate the role of complement C3 levels, the extent of complement activation and of complement hemolytic activity in serum, as potential new biomarkers for the severity of anorexia nervosa. This was a prospective cohort study on 14 patients with severe anorexia nervosa, as defined by a body mass index (BMI) <14 kg/m2. Serum samples were obtained in a biweekly manner until hospital discharge. A total of 17 healthy subjects with normal BMI values served as controls. The serum levels of complement C3, C3a, C5a, sC5b-9, and of the 50% hemolytic complement activity (CH50) were quantified and correlated with the BMIs of patients and control subjects. Serum C3 levels were significantly lower in patients with anorexia nervosa than in controls (median 3.7 (interquartile range (IQR) 2.5-4.9) vs 11.4 (IQR 8.9-13.7, P <0.001). In contrast, complement activation fragments and CH50 levels were not significantly different between the two groups. There was a strong correlation between index C3 levels and BMI (Spearman correlation coefficient = 0.71, P <0.001). Complement C3 serum levels may represent a sensitive new biomarker for monitoring the severity of disease in anorexia nervosa. The finding from this preliminary pilot study will require further investigation in future prospective large-scale multicenter trials.
Tài liệu tham khảo
Hudson JI, Hiripi E, Pope HG, Kessler RC: The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007, 61: 348-358. 10.1016/j.biopsych.2006.03.040.
Mehler PS, Krantz M: Anorexia nervosa medical issues. J Womens Health. 2003, 12: 331-340. 10.1089/154099903765448844.
Steinhausen HC: The outcome of anorexia nervosa in the 20th century. Am J Psychiatry. 2002, 159: 1284-1293. 10.1176/appi.ajp.159.8.1284.
Mehler PS, Winkleman AB, Andersen DM, Gaudiani JL: Nutritional rehabilitation: practical guidelines for refeeding the anorectic patient. J Nutr Metab. 2010, pii: 625782-
Schwartz BI, Mansbach JM, Marion JG, Katzman DK, Forman SF: Variations in admission practices for adolescents with anorexia nervosa: a North American sample. J Adolesc Health. 2008, 43: 425-431. 10.1016/j.jadohealth.2008.04.010.
Krantz MJ, Lee D, Donahoo WT, Mehler PS: The paradox of normal serum albumin in anorexia nervosa: a case report. Int J Eat Disord. 2005, 37: 278-280. 10.1002/eat.20129.
Narayanan V, Gaudiani JL, Mehler PS: Serum albumin levels may not correlate with weight status in severe anorexia nervosa. Eat Disord. 2009, 17: 322-326. 10.1080/10640260902991202.
Gaudiani J, Sabel AL, Mascolo M, Mehler PS: Severe anorexia nervosa: Outcomes from a medical stabilization unit. Int J Eat Disord.
Mehler PS, Weiner KL: Use of total parenteral nutrition in the refeeding of selected patients with severe anorexia nervosa. Int J Eat Disord. 2007, 40: 285-287. 10.1002/eat.20371.
Narayanan V, Gaudiani J, Harris RH, Mehler PS: Liver function test abnormalities in anorexia nervosa - cause or effect. Int J Eat Disord. 2010, 43: 378-381.
Mehler PS, MacKenzie TD: Treatment of osteopenia and osteoporosis in anrexia nervosa: a systematic review of the literature. Int J Eat Disord. 2009, 42: 195-201. 10.1002/eat.20593.
Prince AC, Brooks SJ, Stahl D, Treasure J: Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. Am J Clin Nutr. 2009, 89: 755-765. 10.3945/ajcn.2008.27056.
Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA: Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006, 12: 682-687. 10.1038/nm1419.
Stahel PF, Barnum SR: The role of the complement system in CNS inflammatory diseases. Expert Rev Clin Immunol. 2006, 2: 445-456. 10.1586/1744666X.2.3.445.
Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008, 8: 776-787. 10.1038/nri2402.
Schreiber H, Rittirsch D, Flierl M, Brueckner U, Schneider M, Weiss M, Gebhard F, Huber-Lang M: Complement activation during sepsis in humans. Adv Exp Med Biol. 2006, 586: 217-226. 10.1007/0-387-34134-X_15.
Gaudiani JL, Kashuk JL, Chu ES, Narayanan V, Mehler PS: The use of thrombelastography to determine coagulation status in severe anorexia nervosa: a case series. Int J Eat Disord. 2010, 43: 382-385.
Cleary BS, Gaudiani JL, Mehler PS: Interpreting the complete blood count in anorexia nervosa. Eat Disord. 2010, 18: 132-139. 10.1080/10640260903585540.
Huber-Lang M, Younkin EM, Sarma JV, Riedemann N, McGuire SR, Lu KT, Kunkel R, Younger JG, Zetoune FS, Ward PA: Generation of C5a by phagocytic cells. Am J Pathol. 2002, 161: 1849-1859. 10.1016/S0002-9440(10)64461-6.
Monteleone P, Di Lieto A, Martiadis V, Pannuto M, Maj M: Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa. Mol Psychiatry. 2003, 8: 680-684. 10.1038/sj.mp.4001304.
Palmblad J, Fohlin L, Norberg R: Plasma levels of complement factors 3 and 4, orosomucoid and opsonic functions in anorexia nervosa. Acta Paediatr Scand. 1979, 68: 617-618. 10.1111/j.1651-2227.1979.tb05067.x.
Wyatt RJ, Farrell M, Berry PL, Forristal J, Maloney MJ, West CD: Reduced alternative complement pathway control protein levels in anorexia nervosa: response to parenteral alimentation. Am J Clin Nutr. 1982, 35: 973-980.
Sigal LH, Snyder BK: Low serum complement levels in anorexia nervosa. Am J Dis Child. 1989, 143: 1391-1392.
Pomeroy C, Mitchell J, Eckert E, Raymond N, Crosby R, Dalmasso AP: Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity. Clin Exp Immunol. 1997, 108: 507-515. 10.1046/j.1365-2249.1997.3921287.x.
Nova E, Lopez-Vidriero I, Varela P, Toro O, Casas JJ, Marcos AA: Indicators of nutritional status in restricting-type anorexia nervosa patients: a 1-year follow-up study. Clin Nutr. 2004, 23: 1353-1359.
Flierl MA, Stahel PF, Rittirsch D, Huber-Lang M, Niederbichler AD, Hoesel LM, Touban BM, Morgan SJ, Smith WR, Ward PA, Ipaktchi K: Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit Care. 2009, 13: R12-10.1186/cc7710.
Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, Schmal H, Friedl HP, Ward PA: Protective effects of C5a blockade in sepsis. Nat Med. 1999, 5: 788-792. 10.1038/10512.
Leinhase I, Schmidt OI, Thurman JM, Hossini AM, Rozanski M, Taha ME, Scheffler A, John T, Smith WR, Holers VM, Stahel PF: Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. Exp Neurol. 2006, 199: 454-464. 10.1016/j.expneurol.2006.01.033.
Flierl MA, Perl M, Rittirsch D, Bartl C, Schreiber H, Fleig V, Schlaf G, Liener U, Brueckner UB, Gebhard F, Huber-Lang MS: The role of C5a in the innate immune response after experimental blunt chest trauma. Shock. 2008, 29: 25-31.
Riedemann NC, Ward PA: Complement in ischemia reperfusion injury. Am J Pathol. 2003, 162: 363-367. 10.1016/S0002-9440(10)63830-8.